InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Timothy Eugene Sullivan, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 18 open-market SEC Form 4 transactions: 0 purchases worth $0 and 18 sales worth $6.6M, reported from Jun 5, 23 to Jan 22, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 10.3K | $21.77 | $224K |
| Jan 20, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 2.9K | $19.79 | $57K |
| Jan 13, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.9K | $22.19 | $86K |
| Oct 21, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 10.0K | $28.03 | $280K |
| Sep 8, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 32.7K | $27.86 | $912K |
| Jan 29, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 546 | $29.52 | $16K |
| Jan 22, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.1K | $30.43 | $94K |
| Jan 17, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 1.7K | $29.96 | $52K |
| Jan 13, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 2.2K | $28.70 | $62K |
| Apr 1, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 4.0K | $58.66 | $235K |
| Mar 1, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 4.0K | $63.95 | $251K |
| Feb 12, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 1.4K | $67.77 | $97K |
| Jan 29, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 906 | $64.14 | $58K |
| Jan 22, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.6K | $65.00 | $231K |
| Jan 16, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 2.2K | $66.81 | $149K |
| Nov 30, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 13.9K | $54.79 | $758K |
| Jul 3, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.3K | $91.10 | $297K |
| Jun 5, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 30.6K | $90.60 | $2.7M |